Trial
NCT03770494
A Study of LY3405105 in Participants With Advanced Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Solid Tumor
Intervention
LY3405105
Why stopped
The study was terminated for lack of sufficient efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-04